Skip to main content

Yervoy 50 mg/10 mL injection Images

Generic Name: ipilimumab

This medication has been identified as Yervoy 50 mg/10 mL injection. It is supplied by Bristol-Myers Squibb Company.

Yervoy is used in the treatment of Melanoma; Colorectal Cancer; Melanoma, Metastatic; Renal Cell Carcinoma; Malignant Pleural Mesothelioma and belongs to the drug class anti-CTLA-4 monoclonal antibodies. Risk cannot be ruled out during pregnancy. Yervoy 50 mg/10 mL injection is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Yervoy 50 mg/10 mL injection medicine

Yervoy

Generic Name
ipilimumab
Strength
50 mg/10 mL injection
Availability
Prescription only
Drug Class
Anti-CTLA-4 monoclonal antibodies
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Bristol-Myers Squibb Company
National Drug Code (NDC)
00003-2327

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.